ENTITY
Hutchmed China Ltd

Hutchmed China Ltd (13 HK)

177
Analysis
IndustrialsHong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Refresh
07 Dec 2016 10:02

ANIMAL SPIRITS REPORT: Investment Outlook - Emerging Markets Trumped but Japan Escapes Value Trap

"Overweights" - Japan and Taiwan "Underweights" - India, Singapore, Indonesia, and the Philippines Recent Upgrades - Japan, Taiwan, and...

Share
07 Dec 2016 09:40

ANIMAL SPIRITS REPORT: Country and Sector Earnings Revision Summary (Dec 2016)

Country and Sector Earnings Revision Summary J-curve effects apparent in Europe, Australia, and Japan Emerging market earnings revision...

Share
07 Dec 2016 09:20

ANIMAL SPIRITS REPORT: APAC Valuation Snapshot (Dec 2016)

Japanese valuations are compelling Emerging markets have re-rated Korea discount intact MSCI China significantly lower valuation than MSCI China...

Share
07 Dec 2016 08:49

ANIMAL SPIRITS REPORT: APAC Equity Strategy Quarterly Review - Markets, Macro, Themes, and Stocks

Quarterly Review - Macro, Country, Sector, Thematic and Equity Ideas Anticipated the reflationary regime shift, the Fed "hot" policy and the BOJ...

Share
x